Distribution Records Clause Samples
The Distribution Records clause requires parties to maintain accurate and up-to-date records of all distributions made under the agreement. This typically involves documenting the amounts, dates, and recipients of any payments or distributions, and may require parties to make these records available for inspection or audit upon request. By establishing clear recordkeeping obligations, this clause ensures transparency and accountability in the distribution process, helping to prevent disputes and facilitate compliance with the agreement's terms.
POPULAR SAMPLE Copied 2 times
Distribution Records. A▇▇▇▇▇ shall maintain distribution records that contain all of the appropriate information as specified in cGMP.
Distribution Records. Distributor agrees to maintain and make available upon request from SynCardia and/or regulatory authorities, distribution records of all products sold by the Distributor by Product lot number or as otherwise required. Distributor acknowledges that this information is required for full Product traceability and to minimize risk in case of a product field correction or recall or other reporting obligation to health authorities.
Distribution Records. ▇▇▇▇▇▇ shall maintain for the time periods required by applicable Legal Requirements all of its manufacturing and analytical records, shipment and distribution records and validation data relating to Client Product supplied hereunder, all of which shall contain all of the appropriate information as specified in cGMP.
Distribution Records. In order to enable the Company to comply with the requirements of the European Code of Good Manufacturing Practice (Volume IV of the Rules Governing Medical Products in the European Community), the Distributor shall keep Distribution Records for each Batch of the Product sold to the customers. This information shall be made available to the Company in case of Recall Operation or upon request, within two working days, by sending a fax, confirmed by a letter, to: ViraNative AB Viragen (Scotland) LTD. Tvistevagen 48 Pentland Science Park S-907 ▇▇ ▇▇▇▇ ▇▇▇▇ ▇▇▇▇, Peniculk Sweden Midlothian EH260 PPZ United Kingdom Tel.: ▇▇-▇▇-▇▇▇▇▇▇ Tel.: ▇▇-▇▇▇-▇▇▇-▇▇▇▇ Fax: ▇▇-▇▇-▇▇▇▇▇▇ Fax: ▇▇-▇▇▇-▇▇▇-▇▇▇▇
Distribution Records. BPS shall maintain distribution records that contain all of the appropriate information as specified in, and as necessary to comply with, cGMP. [ * ] Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities NUVELO and Exchange Act of 1934, as amended. 5.7 Customer Complaints and Adverse Events: NUVELO, as required by cGMP, shall maintain all customer complaint and adverse event files. Any such complaints received by BPS shall be forwarded to NUVELO. NUVELO shall be responsible for the review of the complaint or adverse event to determine the need for an investigation or the need to report to the FDA as required by cGMP. NUVELO shall send to BPS all Drug Product performance or manufacturing-related complaints that relate to BPS’ Production which require investigation and shall provide to BPS reasonable samples of all Drug Product which is the subject of such complaints. BPS shall conduct an investigation for each Drug Product performance or manufacturing-related complaint for which BPS receives a sample and shall report findings and follow-up of each investigation to NUVELO. NUVELO shall make these complaint files available to BPS if and to the extent that they are required during an FDA inspection.
Distribution Records. In order to enable the Company to comply with the requirements of the European Code of Good Manufacturing Practice (Volume IV of the Rules Governing Medical Products in the European Community), the Distributor shall keep Distribution Records for each Batch of the Product sold to the customers. This information shall be made available to the Company in case of Recall Operation or upon request, within two working days, by sending a fax, confirmed by a letter, to: BioNative AB Viragen (Scotland) LTD. Tvistevagen 48 Pentland Science Park S-907 36 Umea Bush Loan, Peniculk ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇ EH260 PPZ ▇▇▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇ ▇▇: ▇▇-▇▇-▇▇▇▇▇▇ ▇▇▇ ▇▇: ▇▇-131-445-6268 ▇▇▇ ▇▇: 46-90-193736 ▇▇▇ ▇▇: ▇▇-131-445-6269
Distribution Records. Traceability is not only a requirement of an effective quality system but also the requirement of regulatory bodies around the world. Keeping proper and appropriate distribution records is an important component of ensuring traceability of products in the market. An effective complaint handling system is an important part of any quality system. Any complaint received on a medical device should be evaluated and if necessary, thoroughly investigated and analysed, and corrective actions should be taken. The results of the evaluation should lead to a conclusion regarding whether the complaint was valid, the causes of the complaint, and what actions were necessary to prevent further occurrences. Physical Manufacturers, authorised representative and authorised distributors of medical devices are to:- • maintain records of complaint reports and of actions taken in response to these reports, and produce such records for inspection by the Regulatory Authority in the Member State or an enforcement officer as and when required; and • establish and implement documented procedures to conduct effective and timely investigations of reported problems. A number of post-marketing risk assessment measures to ensure the continued safe use of medical devices. These measures include reporting from healthcare professionals, mandatory reporting from medical device dealers, and exchange of regulatory information with other medical device regulatory agencies. The mandatory reporting of AEs by medical device dealers is an important part of the post-market surveillance system. The objective of AE reporting and subsequent evaluations is to improve protection of the health and safety of patients, users and others by disseminating information that may reduce the likelihood of, or prevent repetition of AEs, or alleviate consequences of such repetition.
Distribution Records. ▇▇▇▇▇▇▇▇ agrees to provide Company on a monthly basis with the names, contact information and addresses of customers of Reseller to whom Products were distributed in the preceding month.
Distribution Records. In order to enable the Company to comply with the requirements of the European Code of Good Manufacturing Practice (Volume IV of the Rules Governing Medical Products in the European Community), the Distributor shall keep Distribution Records for each Batch of the Product sold to the customers. This information shall be made available to the Company in case of Recall Operation, within two working days, by sending a fax, confirmed by a letter, to: ViraNative AB T▇▇▇▇▇▇▇▇▇▇ ▇▇ ▇-▇▇▇ ▇▇ ▇▇▇▇ ▇▇▇▇▇▇ Tel no: 4▇-▇▇-▇▇▇▇▇▇ Fax no: 4▇-▇▇-▇▇▇▇▇▇
Distribution Records. You agree to maintain adequate books and records of any Donated Goods you may obtain from Good360 as required by applicable tax regulations, and to make such records available upon request to Good360 and/or the Internal Revenue Service. Records should include, but are not limited to, accurate records of any individual recipients of Donated Goods and EXACT NAMES AND QUANTITIES OF DONATED GOODS RECEIVED BY THOSE INDIVIDUAL RECIPIENTS. • You further agree to provide adequate substantiation and records of your distribution of the Donated Goods to the Internal Revenue Service and/or Good360 promptly upon request. • You agree to adhere to a nondiscrimination policy in accordance with applicable state and federal law.